Company intelligence / Profile preview

Rescu

Ownership: Private
Development stage: Commercial

Overview

ResQ Biotech is developing proprietary research tools and a drug discovery platform to identify leads against protein misfolding diseases such as Alzheimer's disease and ALS. The company has several ongoing preclinical research programs but no clinical-stage assets yet[1].

Therapeutic areas: Neurology
Modalities: Small moleculeResearch tools
Industry: Biotech

Partnerships

Patras Science Park S.A.National Hellenic Research Foundation

Beyond the preview

Go deeper on Rescu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rescu.

Explore the full profile